The Pennant Group, Inc. (NASDAQ: PNTG) is a Healthcare company (Medical - Care Facilities) with a market capitalization of $1.3B. The Maz Rating grades it against the other companies in its sector.
The Pennant Group, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $36.50, The Pennant Group, Inc. trades at 35.4x trailing earnings, 1.1x sales and 3.4x book value, with an EV/EBITDA of 23.5. Over the last twelve months it generated about $1.2B of revenue and $36M of net income. It runs a gross margin of 13.4%, an operating margin of 5.9% and a net margin of 3.1%. It shows return on equity of 10.2%, return on invested capital of 5.6% and a free cash flow yield of 2.0%. On the balance sheet: a debt-to-equity ratio of 1.28 and a current ratio of 1.18. Over the past 52 weeks the share price ranged from $25.57 to $44.24, with a beta of 1.30.
The Pennant Group, Inc. does not currently pay a dividend.
7 Wall Street analyst ratings cover the stock: 6 Buy and 1 Hold, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.